Press Release VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb 11 hours ago
Press Release VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth Jul 24
Press Release VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTACĀ® Technology Platforms and Portfolio Jul 23